Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

DEVICE(10)
OTHER(3)
BIOLOGICAL(1)
CliniMACs
2 trials
not_applicable
childrens-hospital-of-philadelphia, timothy-olson
Apha/beta T and CD19+ cell depletion using CliniMACS device
1 trial
phase_2
childrens-hospital-of-philadelphia
Phase 1 Dose Level 1
1 trial
phase_1_2
childrens-hospital-of-philadelphia
CliniMACS α/β T-Cell and CD19+ B-Cell Depleted Peripheral Blood Stem Cell Transplant
1 trial
not_applicable
childrens-hospital-of-philadelphia
Transplant of stem cells with CD3+/CD19+ depletion (CliniMACs)
1 trial
early_phase_1
childrens-hospital-of-philadelphia
CliniMACS Cell Processing System for TCRαβ + T Cell and CD45RA Depleted Peripheral Stem Cell Addback
1 trial
not_applicable
childrens-hospital-of-philadelphia
MRD-BMT with Fludarabine-based RIC for Acquired AA
1 trial
early_phase_1
childrens-hospital-of-philadelphia
MRD-BMT with Fludarabine-based RIC for iBMF with trilineage aplasia
1 trial
early_phase_1
childrens-hospital-of-philadelphia

+5 more interventions

13 unique interventions3 categories

Analytics

Trial Phases

Phase 11
Phase 22

Trial Status

Completed2
Recruiting3
Other3

Role Distribution

Principal Investigator8
PI Rate100%

Activity Timeline

Clinical Trials (8)

NCT06839456Phase 1/2Recruiting
Phase 1/2: CD45RA Depleted Stem Cell Addback to Prevent Viral or Fungal Infections Post TCRab/CD19 Depleted HSCT
Acquired Aplastic AnemiaBone Marrow FailureHemoglobinopathies+11 more
PrincipalinvestigatorStart date: 2025-03-21
NCT04523376Not ApplicableCompleted
Pilot Study PBSCT With TCRab Depletion For Hemoglobinopathies
Sickle Cell DiseaseThalassemia Major
PrincipalinvestigatorStart date: 2020-05-14
NCT03810196Not ApplicableRecruiting
CD45RA Depleted Peripheral Stem Cell Addback for Viral or Fungal Infections Post TCRαβ/CD19 Depleted HSCT
Acute LeukemiaAcute Lymphoblastic LeukemiaAcute Myeloid Leukemia+5 more
PrincipalinvestigatorStart date: 2019-03-01
NCT03047746Not ApplicableActive Not Recruiting
Unrelated And Partially Matched Related Donor PSCT w/ T Cell Receptor (TCR) αβ Depletion for Patients With BMF
Acquired Aplastic AnemiaInherited Bone Marrow Failure SyndromesParoxysmal Nocturnal Hemoglobinuria
PrincipalinvestigatorStart date: 2017-02-01
NCT02323867Not ApplicableCompleted
Allogeneic Stem Cell Transplant With Alpha/Beta T AND B Cell Depletion for Hematologic Malignancies
LeukemiaLymphomaMyelodysplasia
PrincipalinvestigatorStart date: 2014-10-01
NCT02356653Early Phase 1Recruiting
Expanded Access Protocol Using CD3+/CD19+ Depleted PBSC
Bone Marrow Failure SyndromesImmunodeficienciesImmunodysregulation Polyendocrinopathy Enteropathy X-linked Syndrome+2 more
Principalinvestigator
NCT02928991Early Phase 1Active Not Recruiting
Fludarabine Based RIC for Bone Marrow Failure Syndromes
Bone Marrow Failure Syndromes
Principalinvestigator
NCT02990819Phase 2Active Not Recruiting
Alpha/Beta T and CD19+ Depleted Peripheral Stem Cells for Patients With Primary Immunodeficiencies
Immune Dysregulation SyndromesImmunodeficiencies
Principalinvestigator

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Mary Horowitz, MD

Center for International Blood and Marrow Transplant Research

Related
24 trials

Shared therapeutic areas:

LeukemiaLymphomaAcute Leukemia+5 more
Similarity Score8%

Jorge Cortes, MD

M.D. Anderson Cancer Center

Related
24 trials

Shared therapeutic areas:

LeukemiaLeukemia, Myeloid, AcuteMyelodysplastic Syndromes+2 more
Similarity Score5%

Brigitte C Widemann, M.D.

National Cancer Institute (NCI)

Related
19 trials

Shared therapeutic areas:

Precursor Cell Lymphoblastic Leukemia-LymphomaLeukemia, Myeloid, AcuteLeukemia+1 more
Similarity Score4%

Jae Park, MD

Memorial Sloan Kettering Cancer Center

Related
17 trials

Shared therapeutic areas:

LeukemiaPrecursor Cell Lymphoblastic Leukemia-LymphomaLeukemia, Myeloid, Acute+1 more
Similarity Score4%

Areej El-Jawahri, MD

Massachusetts General Hospital

Related
21 trials

Shared therapeutic areas:

Leukemia, Myeloid, AcuteHigh Risk Acute Myeloid LeukemiaLymphoma+1 more
Similarity Score4%

Qifa Liu

Nanfang Hospital, Southern Medical University

Related
33 trials

Shared therapeutic areas:

Leukemia, Myeloid, AcuteMyelodysplastic SyndromesAcute Leukemia+1 more
Similarity Score4%

Guillermo Garcia-Manero, MD

M.D. Anderson Cancer Center

Related
18 trials

Shared therapeutic areas:

LeukemiaMyelodysplastic SyndromesLeukemia, Myeloid, Acute+1 more
Similarity Score4%

Gary Schiller, MD

University of California, Los Angeles

Related
3 trials

Shared therapeutic areas:

LeukemiaLymphomaAnemia, Sickle Cell
Similarity Score3%

Courtney DiNardo, MD

M.D. Anderson Cancer Center

Related
16 trials

Shared therapeutic areas:

Leukemia, Myeloid, AcuteLeukemiaMyelodysplastic Syndromes
Similarity Score3%

Helen Heslop, MD

Baylor College of Medicine

Related
17 trials

Shared therapeutic areas:

Precursor Cell Lymphoblastic Leukemia-LymphomaLeukemiaLymphoma
Similarity Score3%

Publications (0)

No publications found for this investigator.

Clinical Trials (8)

Showing 8 of 8 trials

NCT06839456Phase 1/2PrincipalInvestigator

Phase 1/2: CD45RA Depleted Stem Cell Addback to Prevent Viral or Fungal Infections Post TCRab/CD19 Depleted HSCT

Acquired Aplastic AnemiaBone Marrow FailureHemoglobinopathies+11 more
Recruiting
NCT04523376Not ApplicablePrincipalInvestigator

Pilot Study PBSCT With TCRab Depletion For Hemoglobinopathies

Sickle Cell DiseaseThalassemia Major
Completed
NCT03810196Not ApplicablePrincipalInvestigator

CD45RA Depleted Peripheral Stem Cell Addback for Viral or Fungal Infections Post TCRαβ/CD19 Depleted HSCT

Acute LeukemiaAcute Lymphoblastic LeukemiaAcute Myeloid Leukemia+5 more
Recruiting
NCT03047746Not ApplicablePrincipalInvestigator

Unrelated And Partially Matched Related Donor PSCT w/ T Cell Receptor (TCR) αβ Depletion for Patients With BMF

Acquired Aplastic AnemiaInherited Bone Marrow Failure SyndromesParoxysmal Nocturnal Hemoglobinuria
Active Not Recruiting
NCT02323867Not ApplicablePrincipalInvestigator

Allogeneic Stem Cell Transplant With Alpha/Beta T AND B Cell Depletion for Hematologic Malignancies

LeukemiaLymphomaMyelodysplasia
Completed
NCT02356653Early Phase 1PrincipalInvestigator

Expanded Access Protocol Using CD3+/CD19+ Depleted PBSC

Bone Marrow Failure SyndromesImmunodeficienciesImmunodysregulation Polyendocrinopathy Enteropathy X-linked Syndrome+2 more
Recruiting
NCT02928991Early Phase 1PrincipalInvestigator

Fludarabine Based RIC for Bone Marrow Failure Syndromes

Bone Marrow Failure Syndromes
Active Not Recruiting
NCT02990819Phase 2PrincipalInvestigator

Alpha/Beta T and CD19+ Depleted Peripheral Stem Cells for Patients With Primary Immunodeficiencies

Immune Dysregulation SyndromesImmunodeficiencies
Active Not Recruiting

All 8 trials loaded